DEVELOPMENTAL PROCESSES IN SCHIZOPHRENIC DISORDERS - LONGITUDINAL-STUDIES OF VULNERABILITY AND STRESS

被引:354
作者
NUECHTERLEIN, KH
DAWSON, ME
GITLIN, M
VENTURA, J
GOLDSTEIN, MJ
SNYDER, KS
YEE, CM
MINTZ, J
机构
[1] UNIV SO CALIF, DEPT PSYCHOL, LOS ANGELES, CA 90089 USA
[2] UNIV CALIF LOS ANGELES, DEPT PSYCHOL, LOS ANGELES, CA 90024 USA
关键词
D O I
10.1093/schbul/18.3.387
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The Developmental Processes in Schizophrenic Disorders project is a longitudinal study of schizophrenic patients who have recently had a first episode of psychosis. The project focuses on discriminating characteristics of schizophrenic patients that are "stable vulnerability indicators," "mediating vulnerability factors," and "episode indicators" by comparing normal subjects to schizophrenic patients assessed in clinically remitted and psychotic states. A parallel project goal is to identify predictors of relapse, social and work impairment, and illness course among potential psychobiological vulnerability factors and environmental potentiating factors. Hypothesized vulnerability factors and potential environmental stressors are examined first under standardized maintenance antipsychotic medication conditions for at least 1 year. Patients showing stable remission of psychosis after 1 year of maintenance antipsychotic medication are invited to enter drug crossover and withdrawal protocols to determine the need for continuous antipsychotic medication. Vulnerability and stress factors are again assessed. A summary of results to date is presented. Deficits in early components of processing visual arrays and in sustained discrimination of successive ambiguous perceptual inputs are relatively stable across psychotic and clinically remitted states in the schizophrenic patients. Performance on a vigilance task demanding active, working memory also remains abnormal during clinical remission but covaries significantly with psychotic state and is a candidate for a mediating vulnerability factor. Autonomic activation level does not appear to be an enduring vulnerability factor, but it predicts the extent of short-term symptomatic recovery and may mediate the impact of stressors. Under conditions of standardized, injectable antipsychotic medication, independent stressful life events and highly critical attitudes toward the patient in the social environment predict relapse risk. Prospective data suggest that signs and symptoms prodromal to psychotic relapse may be present in about 60 percent of patients.
引用
收藏
页码:387 / 425
页数:39
相关论文
共 174 条
[1]  
American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3rd
[2]  
American Psychiatric Association, 1987, DSM 3 R DIAGN STAT M, V3rd
[3]  
ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789
[4]  
[Anonymous], 1991, NEUROPSYCHOLOGY PSYC
[5]  
ASARNOW R, 1991, HDB SCHIZOPHRENIA, V5, P335
[6]  
ASARNOW RF, 1988, ARCH GEN PSYCHIAT, V45, P822
[7]   ATTENTIONAL ASSESSMENT OF FOSTER CHILDREN AT RISK FOR SCHIZOPHRENIA [J].
ASARNOW, RF ;
STEFFY, RA ;
MACCRIMMON, DJ ;
CLEGHORN, JM .
JOURNAL OF ABNORMAL PSYCHOLOGY, 1977, 86 (03) :267-275
[8]   SCHIZOAFFECTIVE ILLNESS, SCHIZOPHRENIA AND AFFECTIVE-DISORDERS - MORBIDITY RISK AND GENETIC TRANSMISSION [J].
BARON, M ;
GRUEN, R ;
ASNIS, L ;
KANE, J .
ACTA PSYCHIATRICA SCANDINAVICA, 1982, 65 (04) :253-262
[9]   GENETIC-FACTORS FOR THE SPAN OF APPREHENSION TEST - A STUDY OF NORMAL TWINS [J].
BARTFAI, A ;
PEDERSEN, NL ;
ASARNOW, RF ;
SCHALLING, D .
PSYCHIATRY RESEARCH, 1991, 38 (02) :115-124
[10]  
BEBBINGTON P, 1988, SCHIZOPHRENIA MAJOR, P201